Robertson Brigitte 4
4 · YUMANITY THERAPEUTICS, INC. · Filed Dec 28, 2020
Insider Transaction Report
Form 4
Robertson Brigitte
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-12-22+59,035→ 59,035 totalExercise: $8.16Exp: 2029-12-15→ Common Stock (59,035 underlying)
Footnotes (3)
- [F1]On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. ("Merger Sub"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC ("Holdings"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity.
- [F2]25% of the shares subject to the option vested on November 18, 2020. The remaining 75% vest in equal monthly installments over the subsequent three years.
- [F3]Received in the Merger in exchange for a stock option to acquire 280,000 shares of Yumanity, Inc. common stock for $1.72 per share.